176 related articles for article (PubMed ID: 22391344)
1. Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites.
Kalambokis GN; Mouzaki A; Rodi M; Pappas K; Fotopoulos A; Xourgia X; Tsianos EV
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):815-8. PubMed ID: 22391344
[TBL] [Abstract][Full Text] [Related]
2. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia.
Kalambokis GN; Mouzaki A; Rodi M; Tsianos EV
Liver Int; 2012 Mar; 32(3):467-75. PubMed ID: 22098272
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
4. Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.
Hanafy AS; Hassaneen AM
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1455-1461. PubMed ID: 27622998
[TBL] [Abstract][Full Text] [Related]
5. Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.
Kimer N; Pedersen JS; Busk TM; Gluud LL; Hobolth L; Krag A; Møller S; Bendtsen F;
Hepatology; 2017 Feb; 65(2):592-603. PubMed ID: 27775818
[TBL] [Abstract][Full Text] [Related]
6. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
Mostafa T; Badra G; Abdallah M
Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis.
Vlachogiannakos J; Viazis N; Vasianopoulou P; Vafiadis I; Karamanolis DG; Ladas SD
J Gastroenterol Hepatol; 2013 Mar; 28(3):450-5. PubMed ID: 23216382
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
10. Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis.
Vlachogiannakos J; Saveriadis AS; Viazis N; Theodoropoulos I; Foudoulis K; Manolakopoulos S; Raptis S; Karamanolis DG
Aliment Pharmacol Ther; 2009 May; 29(9):992-9. PubMed ID: 19210289
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
12. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
Singh V; Dhungana SP; Singh B; Vijayverghia R; Nain CK; Sharma N; Bhalla A; Gupta PK
J Hepatol; 2012 Feb; 56(2):348-54. PubMed ID: 21749847
[TBL] [Abstract][Full Text] [Related]
13. Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
Singh V; Singh A; Singh B; Vijayvergiya R; Sharma N; Ghai A; Bhalla A
Am J Gastroenterol; 2013 Apr; 108(4):560-7. PubMed ID: 23419385
[TBL] [Abstract][Full Text] [Related]
14. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial.
Rasaratnam B; Kaye D; Jennings G; Dudley F; Chin-Dusting J
Ann Intern Med; 2003 Aug; 139(3):186-93. PubMed ID: 12899586
[TBL] [Abstract][Full Text] [Related]
15. [Aldosterone and renin in liver cirrhosis with ascites].
Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
17. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites.
MacGilchrist A; Craig KJ; Hayes PC; Cumming AD
Clin Sci (Lond); 1994 Sep; 87(3):329-35. PubMed ID: 7525142
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
Chen TA; Tsao YC; Chen A; Lo GH; Lin CK; Yu HC; Cheng LC; Hsu PI; Tsai WL
Scand J Gastroenterol; 2009; 44(5):619-25. PubMed ID: 19191184
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
[TBL] [Abstract][Full Text] [Related]
20. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation.
Lee FY; Lu RH; Tsai YT; Lin HC; Hou MC; Li CP; Liao TM; Lin LF; Wang SS; Lee SD
Scand J Gastroenterol; 1996 May; 31(5):500-5. PubMed ID: 8734349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
